VivoSeq
Other

Idiopathic Ventricular Fibrillation

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Idiopathic Ventricular Fibrillation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

2

clinical trials

Recruiting1 · 50%
Unknown status1 · 50%

Trial Activity

MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
Recruiting··Phase 4·NCT07405229·218 enrolled
Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation
Unknown status··Phase 2·NCT05593757·24 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)